118 related articles for article (PubMed ID: 8643200)
21. Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease.
Martín J; de Sequera P; Quiroga JA; Rico M; Fernández M; Arocena C; Caramelo C; Carreño V
Cytokine; 2000 Aug; 12(8):1248-52. PubMed ID: 10930306
[TBL] [Abstract][Full Text] [Related]
22. Plasma and dialysate potassium concentrations and haemodialysis associated mortality.
Adam WR
Nephrology (Carlton); 2013 Oct; 18(10):655-6. PubMed ID: 24073797
[No Abstract] [Full Text] [Related]
23. Interleukin/cytokine profiles in haemodialysis and in continuous peritoneal dialysis.
Jacobs P; Glorieux G; Vanholder R
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V41-45. PubMed ID: 15284359
[TBL] [Abstract][Full Text] [Related]
24. Adsorption-desorption processes of aluminium, zinc and copper on plastic tubing in haemodialysis monitors.
Milacic R; Benedik M; Knezević S
Clin Chim Acta; 1997 Sep; 265(2):169-82. PubMed ID: 9385459
[TBL] [Abstract][Full Text] [Related]
25. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
[TBL] [Abstract][Full Text] [Related]
26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
27. [Dialysate and biocompatibility in hemodialysis].
Berland Y
Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of acute lithium intoxication with high-flux haemodialysis membranes].
Peces R; Fernández EJ; Regidor D; Peces C; Sánchez R; Montero A; Selgas R
Nefrologia; 2006; 26(3):372-8. PubMed ID: 16892827
[TBL] [Abstract][Full Text] [Related]
29. The pathogenesis and consequences of AGE formation in uraemia and its treatment.
Dawnay A; Millar DJ
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1081-94. PubMed ID: 9846890
[TBL] [Abstract][Full Text] [Related]
30. [Bacterial contamination in a dialysis unit].
Fabiani M; Montacutelli R; Raponi M; Orsi GB
Ann Ig; 1999; 11(2):107-16. PubMed ID: 10365478
[No Abstract] [Full Text] [Related]
31. Why and how to monitor bacterial contamination of dialysate?
Pérez-García R; Rodríguez-Benítez PO
Nephrol Dial Transplant; 2000 Jun; 15(6):760-4. PubMed ID: 10831624
[No Abstract] [Full Text] [Related]
32. Profiling dialysis: a new approach to dialysis intolerance.
Bonomini V; Coli L; Scolari MP
Nephron; 1997; 75(1):1-6. PubMed ID: 9031262
[No Abstract] [Full Text] [Related]
33. Neurological manifestations of uraemia and chronic dialysis.
Tzamaloukas AH; Agaba EI
Niger J Med; 2004; 13(2):98-105. PubMed ID: 15293824
[TBL] [Abstract][Full Text] [Related]
34. [An outbreak of gram-negative bacteremia (GNB), especially enterobacter cloacae, in patients with long-term tunnelled haemodialysis catheters].
Rodríguez Jornet A; García García M; Mariscal D; Fontanals D; Cortés P; Coll P; Falcó J; Ramírez N; Mayor S; Mañé N; Miret X; Yuste E
Nefrologia; 2003; 23(4):333-43. PubMed ID: 14558333
[TBL] [Abstract][Full Text] [Related]
35. LIGHT--a new member of the TNF superfamily in the plasma, dialysate and urine of uremic patients; the impact of residual diuresis and presence of viral hepatitis.
Pawlak K; Pawlak D; Mysliwiec M
Clin Biochem; 2007 Nov; 40(16-17):1240-4. PubMed ID: 17826757
[TBL] [Abstract][Full Text] [Related]
36. Haemodialysis fluid: composition and clinical importance.
Hoenich NA; Ronco C
Blood Purif; 2007; 25(1):62-8. PubMed ID: 17170540
[TBL] [Abstract][Full Text] [Related]
37. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis.
Yu TM; Chen YH; Hsu JY; Sun CS; Chuang YW; Chen CH; Wu MJ; Cheng CH; Shu KH
Nephrol Dial Transplant; 2009 Jun; 24(6):1946-51. PubMed ID: 19164324
[TBL] [Abstract][Full Text] [Related]
38. [Surface active compounds present in the dialysate from patients with uremia].
Cichocki T; Hanicki Z; Klein A; Pawełek J
Przegl Lek; 1988; 45(7):549-54. PubMed ID: 3238031
[No Abstract] [Full Text] [Related]
39. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
Shahapuni I; Esper NE; Opisiv R; Massy Z; Choukroun G; Garabedian M; Fournier A
Nephrol Dial Transplant; 2008 Apr; 23(4):1456-7; author reply 1457-8. PubMed ID: 18039645
[No Abstract] [Full Text] [Related]
40. The link between dialysate and chronic inflammatory disease in hemodialysis.
Amato RL
Nephrol Nurs J; 2002 Oct; 29(5):490-2. PubMed ID: 12434456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
